Skip to main content
AegirBio AB logo

AegirBio AB — Investor Relations & Filings

Ticker · AEGIR ISIN · SE0026820854 LEI · 549300MWGS283WZLYI10 ST Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST AEGIR

About AegirBio AB

https://www.aegirbio.com/

AegirBio AB, which changed its name to Magnasense AB in July 2024, is a diagnostics company specializing in therapeutic drug monitoring (TDM). The company develops and provides tests to monitor and optimize the dosage of biological drugs, utilizing a unique, patented technology platform. Its primary focus is on applications within the fields of autoimmune diseases, oncology, and neurology. The company's goal is to make diagnostics more accessible and easier to use, facilitating personalized medicine.

Recent filings

No filings indexed yet

We are still gathering filings for AegirBio AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.